PROCEPT BioRobotics Corporation (PRCT)

NASDAQ: PRCT · Real-Time Price · USD
39.59
-6.10 (-13.35%)
At close: Aug 7, 2025, 4:00 PM
40.20
+0.61 (1.54%)
After-hours: Aug 7, 2025, 7:56 PM EDT
-13.35%
Market Cap2.19B
Revenue (ttm)274.95M
Net Income (ttm)-84.15M
Shares Out 55.33M
EPS (ttm)-1.56
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,918,652
Open42.00
Previous Close45.69
Day's Range37.12 - 42.52
52-Week Range37.12 - 103.81
Beta1.04
AnalystsBuy
Price Target75.57 (+90.88%)
Earnings DateAug 6, 2025

About PRCT

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign p... [Read more]

Sector Healthcare
IPO Date Sep 15, 2021
Employees 756
Stock Exchange NASDAQ
Ticker Symbol PRCT
Full Company Profile

Financial Performance

In 2024, PROCEPT BioRobotics's revenue was $224.50 million, an increase of 64.84% compared to the previous year's $136.19 million. Losses were -$91.41 million, -13.68% less than in 2023.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for PRCT stock is "Buy." The 12-month stock price target is $75.57, which is an increase of 90.88% from the latest price.

Price Target
$75.57
(90.88% upside)
Analyst Consensus: Buy
Stock Forecasts

News

PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call Transcript

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Kevin Waters - Executive VP & CFO Larry L. Wood - Independent Director Ma...

1 day ago - Seeking Alpha

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transfo...

1 day ago - GlobeNewsWire

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

SAN JOSE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (“the Company”), a surgical robotics company focused on advancing patient care by developing transformative solut...

14 days ago - GlobeNewsWire

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformat...

15 days ago - GlobeNewsWire

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transfo...

17 days ago - GlobeNewsWire

Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformat...

24 days ago - GlobeNewsWire

19 stocks at the intersection of AI and robotics that could see big sales boosts

Industrial robots have been around for decades. They're often used on manufacturing lines, where they perform automated tasks.

2 months ago - Market Watch

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solu...

3 months ago - GlobeNewsWire

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

Presentations underscore long-term clinical outcomes, safety  and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN JOSE, Calif., April 24, ...

3 months ago - GlobeNewsWire

PROCEPT BioRobotics Corporation (PRCT) Q1 2025 Earnings Call Transcript

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ET Company Participants Matt Bacso - Vice President, Investor Relations & Business Operations Rez...

3 months ago - Seeking Alpha

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transf...

3 months ago - GlobeNewsWire

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment global...

4 months ago - GlobeNewsWire

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

Aquablation therapy delivers similar symptom score reduction, superior ejaculatory function preservation, and superior continence preservation to laser enucleation in 80–180 mL prostates in a randomiz...

4 months ago - GlobeNewsWire

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transfo...

5 months ago - GlobeNewsWire

Procept BioRobotics: Strong Growth, But Profitability Seems Far Away

PROCEPT BioRobotics shows strong revenue growth and expanding market presence but struggles with profitability and rising operational costs. The company's HYDROS robotic system and consumables busines...

5 months ago - Seeking Alpha

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transfor...

5 months ago - GlobeNewsWire

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solut...

6 months ago - GlobeNewsWire

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

NEW YORK--(BUSINESS WIRE)--Spruce Point Capital Management, LLC (“Spruce Point” or “we” or “us”), a New York-based investment management firm that focuses on forensic research and short-selling, today...

7 months ago - Business Wire

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

SAN JOSE, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solu...

9 months ago - GlobeNewsWire

Procept BioRobotics: Continued Growth Runway Ahead

PRCT's Q3 sales were up 66% YoY, and gross margins reached a record 63%. Management forecasts $223mm in sales this year, with a 64% top-line growth. The business model ensures recurring revenue and op...

9 months ago - Seeking Alpha

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

SAN JOSE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical robotics company focused on advancing patient c...

10 months ago - GlobeNewsWire

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical robotics company focused on advancing patient c...

10 months ago - GlobeNewsWire

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

PROCEPT BioRobotics PRCT stock is trading on Monday after the company released better-than-expected third-quarter earnings.

10 months ago - Benzinga

PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2024 Earnings Conference Call October 28, 2024 8:00 AM ET Company Participants Matt Bacso - Vice President, Investor Relations Reza Zadno - Chief Exec...

10 months ago - Seeking Alpha

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transfor...

10 months ago - GlobeNewsWire